
Please try another search
By Siddharth Cavale
(Reuters) -Reckitt Benckiser Group posted disappointing second-quarter sales growth and warned on margins on Tuesday sending its shares 9% lower as costs rise and easing lockdowns slow growth in products such as Lysol disinfectants.
Like-for-like sales rose 2.2% for the three months to June 30, excluding its infant nutrition business in China, lower than the 2.3% growth analysts had expected, according to a company-supplied consensus.
The stock, down 5% this year, was the top loser on the FTSE 100 index in morning trading.
The pandemic boosted Reckitt's sales to record levels last year, but there are signs that momentum is easing as vaccinations gather pace and stay-at-home restrictions in developed economies are lifted.
Reckitt said brands including Finish, Airwick, Harpic and Veet, which make up 70% of its sales, are growing, but at slower rates than last year, while brands like Durex, Vanish and Nurofen are returning to growth as market conditions normalise.
Its hygiene business, which includes disinfectants and Finish dishwasher pods, saw like-for-like sales rise 7.8%, while its health business, which makes Mucinex cough syrup and Strepsils lozenges, fell 5.6%.
CEO Laxman Narasimhan said trends for its cold and flu products had improved in the second quarter.
Like its peers, the company saw costs rise for plastics and paper as well as higher freight and logistics costs.
Cost of goods sold rose 8-9% in the quarter, Chief Financial Officer Jeff Carr said on a media call.
The company now expects an adjusted operating margin 22.7% to 23.2% for 2021, lower than the 23.6% it generated in 2020.
Adjusted earnings per share for the six months ended June came in at 142.6 pence, below the 144.4 pence average estimate.
The company, which rebranded as Reckitt from RB earlier this year, maintained its full-year sales growth forecast of between 0% and 2%.
The company also reported an operating loss of 1.83 billion pounds in the first half of the year, mainly due to a nearly 3 billion pound charge taken on the sale of its infant nutrition business in China and a 165 million loss on the sale of Scholl - deals that were announced earlier this year.
By Nupur Anand and Chris Thomas MUMBAI (Reuters) -Shares in Life Insurance Corp of India (LIC) slid 5% in their market debut on Tuesday, a fresh setback for the state-owned giant...
BERLIN (Reuters) - Daimler (OTC:DDAIF) Truck Holding increased its forecast for 2022 revenues to 48 - 50 billion euros ($52.21 billion) from 45.5 - 47.5 billion, the truckmaker...
ZURICH (Reuters) - ABB is aiming to increase sales at its motion business 50% quicker than the overall market for electric motors, the Swiss engineering company said on Tuesday...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.